EMMA International Consulting Group, Inc. Company Profile

Background

Overview

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting, specializing in quality, regulatory, and compliance services for the medical device, combination products, and diagnostics industries. Founded in 2013, the company has established itself as a trusted partner for organizations navigating complex regulatory landscapes.

Mission and Vision

EMMA International's mission is to provide cost-effective, end-to-end solutions for organizations operating in complex and regulated environments. The company's vision is to simplify compliance in the highly regulated life sciences sector, ensuring that clients' products advance seamlessly from concept to approval.

Primary Area of Focus

The company focuses on delivering comprehensive consulting services across quality, regulatory, and compliance functions, supporting clients in product development, market readiness, post-market surveillance, and remediation.

Industry Significance

EMMA International has been recognized for its rapid growth and industry impact, including multiple appearances on the Inc. 5000 list, which highlights the fastest-growing private companies in the United States.

Key Strategic Focus

Core Objectives

Simplify compliance processes for clients in the life sciences sector.

Provide end-to-end solutions across quality, regulatory, and compliance functions.

Support clients in product development, market readiness, post-market surveillance, and remediation.

Specific Areas of Specialization

Quality management system development.

Regulatory strategy and submissions.

Post-market compliance.

Key Technologies Utilized

Digital tools for regulatory intelligence.

Data analytics for market assessments.

AI-driven solutions for competitive intelligence.

Primary Markets Targeted

Medical device industry.

Pharmaceutical sector.

Biotechnology field.

Combination products.

Diagnostics industry.

Financials and Funding

Funding History

Specific details regarding EMMA International's funding history are not publicly disclosed.

Recent Funding Rounds

Information about recent funding rounds is not publicly available.

Notable Investors

Investor information is not publicly disclosed.

Utilization of Capital

The company has utilized capital to expand its service offerings, enhance technological capabilities, and support global growth initiatives.

Pipeline Development

Key Pipeline Candidates

EMMA International offers a range of services rather than products in a traditional pipeline. Key service areas include:

Quality management system development.

Regulatory strategy and submissions.

Post-market compliance.

Stages of Development

Services are continuously refined to meet evolving industry standards and client needs.

Target Conditions

The company addresses regulatory and compliance challenges across various sectors, including medical devices, pharmaceuticals, biotechnology, combination products, and diagnostics.

Anticipated Milestones

EMMA International aims to expand its global footprint and service offerings, with milestones including strategic partnerships and service diversification.

Technological Platform and Innovation

Proprietary Technologies

Digital tools for regulatory intelligence.

Data analytics platforms for market assessments.

AI-driven solutions for competitive intelligence.

Significant Scientific Methods

Regulatory intelligence mapping.

Clinical trial benchmarking.

Competitive landscape assessments.

Leadership Team

Executive Profiles

Carmine Jabri, Ph.D., MHA – Chief Executive Officer. Dr. Jabri has extensive experience in regulatory compliance and has been instrumental in EMMA International's growth and strategic direction.

Kira Jabri – Chief Operating Officer. Ms. Jabri oversees daily operations and has played a key role in expanding the company's service offerings.

Madison Green – Director of Technical Operations. Ms. Green leads technical initiatives and ensures the integration of innovative solutions into the company's services.

Competitor Profile

Market Insights and Dynamics

The regulatory compliance consulting market is characterized by rapid growth, driven by increasing regulatory complexities and the need for specialized expertise across various industries.

Competitor Analysis

Validant: Specializes in regulatory, compliance, and quality consulting within the pharmaceuticals, biologics, medical devices, and diagnostics sectors.

Greenlight Guru: Provides electronic quality management systems (eQMS) and clinical data collection solutions for the medical device industry.

Strategic Collaborations and Partnerships

EMMA International has expanded its capabilities through strategic partnerships, including the acquisition of QualityMed Consulting Partners LLC in January 2026, enhancing its support for healthcare and life sciences organizations.

Operational Insights

The company differentiates itself through a comprehensive service model that integrates advisory, operational, and implementation capabilities, providing clients with a cohesive approach to regulatory compliance.

Strategic Opportunities and Future Directions

EMMA International plans to continue expanding its global presence, diversify its service offerings, and leverage technological innovations to enhance service delivery and client satisfaction.